CJC 1295 no DAC dose ranges, timing, and half-life explained for research use, plus how it compares with DAC versions and ipamorelin blends.
The research literature most often describes a CJC 1295 no DAC dose of 100 to 300 micrograms per injection, given one to three times daily, with many protocols favoring injections near sleep. The peptide clears quickly, with a half-life of roughly 30 minutes, so protocols spread or time doses around that short window instead of using once-weekly administration. CJC 1295 without the DAC is not FDA-approved for human use in the United States, and every figure below comes from laboratory or investigational settings rather than approved medical dosing.
What "No DAC" Changes About Dosing
DAC stands for drug affinity complex, a modification that binds the peptide to albumin and slows its breakdown in the body. Removing it produces a much shorter-acting compound, which is why the two versions are rarely dosed the same way.
- With DAC: a half-life of roughly 6 to 8 days in research models, so protocols use fewer, larger injections.
- Without DAC: a half-life of about 30 minutes, so protocols use smaller amounts given more often.
- Practical result: a CJC 1295 no DAC dose is measured in micrograms per injection, not milligrams per week.
Anyone weighing cjc-1295 dac vs no dac should treat them as separate compounds with separate dosing logic. The DAC version accumulates in circulation, while the no-DAC version rises and falls within the hour.
Typical CJC 1295 No DAC Dose Ranges Reported in Research
Reported cjc-1295 no dac dosage patterns cluster around a few common numbers. Most summaries fall between 100 mcg and 300 mcg per injection, with total daily exposure staying under roughly 600 mcg in the sources that describe amounts at all.
| Reported protocol | Dose per injection | Injections per day | Total daily amount |
|---|---|---|---|
| Low / conservative | 100 mcg | 1-2 | 100-200 mcg |
| Common research range | 100-150 mcg | 2-3 | 200-450 mcg |
| Higher reported range | 300 mcg | 1-2 | 300-600 mcg |
| Stacked with ipamorelin | 100 mcg (CJC 1295 portion) | 2-3 | 200-300 mcg |
These numbers are descriptive, not prescriptive. No regulatory agency has established a safe or effective CJC 1295 no DAC dose for humans, and responses described in unpublished reports vary widely.
Timing, Half-Life, and Why Frequency Matters
The cjc 1295 no dac half-life of roughly 30 minutes explains the injection schedule. A peptide that clears this fast cannot support once-weekly dosing the way the DAC version can.
Most protocols described in research summaries and community threads place injections in the evening or just before sleep, when natural growth hormone release is highest. Some users also time doses around a fasted state to avoid food-related insulin spikes.
- Inject near sleep to align with the body's largest natural growth hormone pulse.
- Leave 2 to 3 hours between the last meal and the injection when possible.
- Space multiple daily injections several hours apart instead of clustering them.
Because the compound is short-lived, delaying a dose shifts blood levels more than it would with a long-acting analog.
Stacking CJC 1295 No DAC With Ipamorelin
CJC 1295 no DAC combined with ipamorelin is one of the most commonly discussed pairings in peptide research and bodybuilding circles. The two act on different receptors, and the working theory is that they may amplify the same growth hormone pulse.
A 10 mg blended vial usually contains 5 mg of each peptide. A typical research injection from that mix delivers about 100 mcg of each compound, given one to three times daily.
Many cjc-1295 no dac ipamorelin reddit threads describe users titrating up slowly and reporting flushing, hunger changes, or tingling hands. Those accounts are anecdotal and are not clinical evidence.
How It Compares With Tesamorelin and Other Options
Tesamorelin is the only peptide in this family with an FDA-approved human indication, which makes the tesamorelin vs cjc-1295 no dac comparison a frequent one. Their dosing scales are not interchangeable.
| Compound | Half-life (research) | Typical research dose | FDA status |
|---|---|---|---|
| CJC 1295 no DAC | ~30 minutes | 100-300 mcg, 1-3x daily | Not approved |
| CJC 1295 with DAC | ~6-8 days | 1-2 mg weekly | Not approved |
| Ipamorelin | ~2 hours | 100-300 mcg, 1-3x daily | Not approved |
| Tesamorelin | ~26-38 minutes | 1-2 mg daily (prescription) | Approved for HIV-related lipodystrophy |
A milligram of tesamorelin and a microgram of CJC 1295 no DAC are not equivalent amounts. Copying a dose from one compound to another is a common and avoidable mistake.
Safety, Sourcing, and Legal Status
CJC 1295 no DAC is sold as a research chemical. Products labeled for research use are not tested or approved for human consumption, and purity varies between vendors.
- Reported side effects include injection site irritation, water retention, fatigue, tingling or numbness, and changes in blood sugar.
- Growth hormone secretagogues can interact with other medications and may be inappropriate for people with certain cancers or endocrine conditions.
- Buying from unverified suppliers raises the risk of contamination or a vial that does not match its label.
Anyone considering these compounds for personal use should speak with a licensed healthcare professional first. A clinician can review medical history, medication interactions, and whether a prescription alternative exists.
Bottom Line on CJC 1295 No DAC Dosing
CJC 1295 no DAC is dosed in small, frequent amounts because of its short half-life, typically 100 to 300 mcg per injection one to three times daily in reported protocols. The DAC version behaves like a different compound and is dosed far less often and in much larger amounts.
CJC 1295 no DAC is not FDA-approved for human use, and no standard human dose exists. Any protocol circulating online is experimental rather than established, so personal use carries unknown risks.
Frequently Asked Questions
What is a typical CJC 1295 no DAC dose?
Most reported research protocols use 100 to 300 mcg per injection, given one to three times daily. Some summaries describe a single larger dose of about 300 mcg before sleep instead. No FDA-approved human dose exists for this peptide.
How long does CJC 1295 no DAC stay active in the body?
Its half-life is roughly 30 minutes in research models, which is why injections are usually timed near sleep or split across the day. The version with DAC lasts far longer, around 6 to 8 days. That difference is the main reason the two are dosed differently.
Is CJC 1295 no DAC the same as CJC 1295 with DAC?
No. The DAC modification binds the peptide to albumin and extends its half-life from about 30 minutes to roughly 6 to 8 days. As a result, the DAC version is studied at milligram amounts given every few days, while the no-DAC version is studied at microgram amounts given daily.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.